Marinus Verwijs

Insider Reports History

Entity
Individual
Location
C/O Aerovate Therapeutics, Inc., 200 Berkeley Street, Floor 18, Boston, MA
Signature
/s/ George A Eldridge, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Marinus Verwijs:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aerovate Therapeutics, Inc. CHIEF TECHNICAL OFFICER Stock Option (Right to Buy) 68.8K $1.13M $16.37 Jun 14, 2024 Direct
Aerovate Therapeutics, Inc. CHIEF TECHNICAL OFFICER Common Stock 0 $0 $25.00 Jun 14, 2024 Direct

Insider Reports Filed by Marinus Verwijs

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AVTE Aerovate Therapeutics, Inc. Jun 14, 2024 3 -$110K 4 Jun 14, 2024 CHIEF TECHNICAL OFFICER
AVTE Aerovate Therapeutics, Inc. May 2, 2024 1 -$41.6K 4 May 3, 2024 CHIEF TECHNICAL OFFICER
AVTE Aerovate Therapeutics, Inc. Apr 1, 2024 4 -$77.4K 4 Apr 3, 2024 CHIEF TECHNICAL OFFICER
AVTE Aerovate Therapeutics, Inc. Mar 19, 2024 4 -$60.9K 4 Mar 20, 2024 CHIEF TECHNICAL OFFICER
AVTE Aerovate Therapeutics, Inc. Jan 22, 2024 1 $0 4 Jan 24, 2024 CHIEF TECHNOLOGY OFFICER
AVTE Aerovate Therapeutics, Inc. Nov 1, 2023 1 -$10.1K 4 Nov 3, 2023 CHIEF TECHNOLOGY OFFICER
AVTE Aerovate Therapeutics, Inc. May 3, 2023 1 -$15.8K 4 May 5, 2023 SENIOR VICE PRESIDENT, CMC
AVTE Aerovate Therapeutics, Inc. Feb 7, 2023 1 $0 4 Feb 8, 2023 SENIOR VICE PRESIDENT, CMC
AVTE Aerovate Therapeutics, Inc. Nov 2, 2022 1 -$21.3K 4 Nov 3, 2022 SENIOR VICE PRESIDENT, CMC
AVTE Aerovate Therapeutics, Inc. Mar 21, 2022 1 $0 4 Mar 23, 2022 Senior Vice President, CMC
AVTE Aerovate Therapeutics, Inc. Mar 21, 2022 0 $0 3 Mar 23, 2022 Senior Vice President, CMC